1 - 70 of about 70
English: Kono M, Wakisaka R, Komatsuda H, Hayashi R, Kumai T, Yamaki H, Sato R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Kobayashi H, Hayashi T, Takahara M., Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancer , Head Neck , 2024
English: Sato R, Yuasa R, Kumai T, Wakisaka R, Komatsuda H, Kono M, Yamaki H, Ishida Y, Wada T, Takahara M, Katada A., Efficacy of Cetuximab Combined with Paclitaxel in Patients with Recurrent Salivary Gland Carcinoma: A Retrospective Observational Study , ORL J Otorhinolaryngol Relat Spec , 2024
English: Nagato T, Komatsuda H, Hayashi R, Takahara M, Ujiie N, Kosaka A, Ohkuri T, Oikawa K, Sato R, Wakisaka R, Kono M, Yamaki H, Ohara K, Kumai T, Kishibe K, Katada A, Hayashi T, Kobayashi H., Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma , Cancer Sci , 2024
English: Hayashi S, Kumai T, Kishibe K, Takahara M, Katada A, Hayashi T., Internal carotid artery dissection caused by elongated styloid process. , Auris Nasus Larynx , 2023
English: Komatsuda H, Kono M, Wakisaka R, Sato R, Inoue T, Kumai T, Takahara M., Harnessing Immunity to Treat Advanced Thyroid Cancer. , Vaccines , 2023
English: Ominato H, Komabayashi Y, Suzuki S, Kunibe I, Kumai T, Takahara M., Hypopharyngeal Diffuse Large B-Cell Lymphoma in a 74-Year-Old Man Presenting with Dysphagia: A Case Report , Am J Case Rep , 2023
English: Ominato H, Kumai T, Ota R, Takahara M., A boy with sore throat and chest pain. , J Am Coll Emerg Physicians Open , 2023
English: Ominato H, Ota R, Kumai T, Takahara M., A woman with massive epistaxis. , J Am Coll Emerg Physicians Open , 2023
English: Inoue T, Kumai T, Ohara K, Takahara M., Cerebral Infarction as a Rare Adverse Event of Immune Checkpoint Inhibitors in Patients With Head and Neck Squamous Cell Carcinoma: A Case Series , Cureus , 2023
English: Kumai T, Inoue T, Sakaue S, Ohara K, Takahara M., An Otogenic Variant of Lemierre's Syndrome Caused by Trueperella bernardiae , Cureus , 2023
English: Kumai T, Shinomiya H, Shibata H, Takahashi H, Kishikawa T, Okada R, Fujieda S, Sakashita M., Translational research in head and neck cancer: Molecular and immunological updates , Auris Nasus Larynx , 2023
English: Tsuda T, Suzuki M, Kato Y, Kidoguchi M, Kumai T, Fujieda S, Sakashita M., The current findings in eosinophilic chronic rhinosinusitis. , Auris Nasus Larynx , 2023
English: Hidekiyo Yamaki, Takumi Kumai, et al, Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer , Cancer Immunology Immunotherapy , 2023 , (IF:6.63)
English: Hayashi S, Kumai T, et al, Internal carotid artery dissection caused by elongated styloid process , Auris Nasus Larynx , 2023 , (IF:2.119)
English: Nagato T, Kumai T, et al., Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy , Cancer Immunology, Immunotherapy , 2023 , (IF:6.63)
English: Komatsuda H, Kumai T, et al, Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulation , Cancer Science , 2023 , (IF:6.716)
English: Komatsuda H, Kumai T, et al, Sensory trick in patients with opsoclonus-myoclonus syndrome , Acta Neurologica Belgica , 2023 , (IF:2.471)
English: Ohara K, Kumai T, et al, Treatment outcomes of alternating chemoradiotherapy for nasopharyngeal carcinoma: a single-center safety and efficacy study , Brazilian Journal of Otorhinolaryngology , 2022 , (IF:2.472)
English: Sato R, Kumai T, et al, The efficacy of PD-1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study , Laryngoscope Investigative Otolaryngology , 2022 , (IF:2.542)
English: Yajima Y, Kumai T, et al, A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity , Cancer Science , 2022 , (IF:6.716)
English: Kumai T, et al, 19th International Symposium on Epstein-Barr Virus and Associated Diseases, 29-30 July 2021, Asahikawa, Japan , Cancers , 2022 , (IF:6.575)
English: Ohara K, Kumai T, et al, Central-part laryngectomy after laryngotracheal separation to manage pharyngocutaneous fistula: A case report and retrospective analysis of 12 cases , Auris Nasus Larynx , 2022 , (IF:1.863)
English: Michihisa Kono 1, Hidekiyo Yamaki 1, Hiroki Komatsuda 1, Takumi Kumai, Ryusuke Hayashi 1, Risa Wakisaka 1, Ryosuke Sato 1, Kenzo Ohara 1, Kan Kishibe 1, Miki Takahara 1, Akihiro Katada 1, Tatsuya Hayashi 2, Yasuaki Harabuchi 1, IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer , Translational Oncology , 2022
English: Takumi Kumai, Hiroki Komatsuda 1, Risa Wakisaka 1, Hidekiyo Yamaki 1, Michihisa Kono 1, Ryusuke Hayashi 1, Kan Kishibe 1, Miki Takahara 1, Akihiro Katada 1, Tatsuya Hayashi 1 2, Yasuaki Harabuchi 1, Concurrent chemoradiotherapy with cisplatin and docetaxel for head and neck squamous cell carcinoma , Clin Otolaryngol , 2022
English: Hisataka Ominato, Takumi Kumai, Yasuaki Harabuchi, Removal of Coin Cell Lithium Battery Lodged in the Pediatric Pharyngoesophageal Junction by Rigid Esophagoscopy; a Case Report , Arch Acad Emerg Med . , 2022
English: Takumi Kumai, Hidekiyo Yamaki 2, Michihisa Kono 2, Ryusuke Hayashi 2, Risa Wakisaka 2, Hiroki Komatsuda 2, Antitumor Peptide-Based Vaccine in the Limelight , Vaccines , 2022
English: Michihisa Kono , Hiroki Komatsuda 1, Hidekiyo Yamaki 1, Takumi Kumai, Ryusuke Hayashi 1, Risa Wakisaka 1, Toshihiro Nagato 3, Takayuki Ohkuri 3, Akemi Kosaka 3, Kenzo Ohara 1, Kan Kishibe 1, Miki Takahara 1, Akihiro Katada 1, Tatsuya Hayashi 1 2, Hiroya Kobayashi 3, Yasuaki Harabuchi 1, Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma , Oncoimmunology , 2022
English: Akemi Kosaka, Kei Ishibashi, Toshihiro Nagato, Hidemitsu Kitamura, Yukio Fujiwara 4, Syunsuke Yasuda 2, Marino Nagata 1, Shohei Harabuchi 1 5, Ryusuke Hayashi 1 5, Yuki Yajima 1, Kenzo Ohara 5, Takumi Kumai 5, Naoko Aoki 1, Yoshihiro Komohara 4, Kensuke Oikawa 1, Yasuaki Harabuchi, Masahiro Kitada, Hiroya Kobayashi, Takayuki Ohkuri , CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes , J Exp Med , 2021
English: Marino Nagata, Akemi Kosaka, Yuki Yajima, Syunsuke Yasuda, Mizuho Ohara, Kenzo Ohara, Shohei Harabuchi, Ryusuke Hayashi, Hiroshi Funakoshi, Jun Ueda, Takumi Kumai, Toshihiro Nagato, Kensuke Oikawa, Yasuaki Harabuchi, Celis Esteban, Takayuki Ohkuri, Hiroya Kobayashi, A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment , Cancer immunology and immunotherapy , 2021
English: Michihisa Kono, Takumi Kumai, Ryusuke Hayashi, Hidekiyo Yamaki, Hiroki Komatsuda, Risa Wakisaka, Toshihiro Nagato, Takayuki Ohkuri, Akemi Kosaka, Kenzo Ohara, Kan Kishibe, Miki Takahara, Akihiro Katada, Tatsuya Hayashi, Esteban Celis, Hiroya Kobayashi, Yasuaki Harabuchi, Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery , Cancer immunology and immunotherapy , 2021
English: Akemi Kosaka, Yuki Yajima, Mayumi Hatayama, Katsuya Ikuta, Takaaki Sasaki, Noriko Hirai, Syunsuke Yasuda, Marino Nagata, Ryusuke Hayashi, Shohei Harabuchi, Kenzo Ohara, Mizuho Ohara, Takumi Kumai, Kei Ishibashi, Yui Hirata-Nozaki, Toshihiro Nagato, Kensuke Oikawa, Yasuaki Harabuchi, Esteban Celis, Toshikatsu Okumura, Yoshinobu Ohsaki, Hiroya Kobayashi, Takayuki Ohkuri, A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy , Cancer science , 2021
English: Miki Takahara, Takumi Kumai, Kan Kishibe, Toshihiro Nagato, Yasuaki Harabuchi, Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein-Barr Virus Relation , Microorganisms , 2021
English: Takumi Kumai, Kan Kishibe, Tatsuya Hayashi, Yasuaki Harabuchi, Laryngeal recurrence of extranodal NK/T cell lymphoma , eJHaem , 2021
English: Kishibe K,Hayashi T,Harabuchi Y., Laryngeal recurrence of extranodal NK/T cell lymphoma , ejHaem , 2021
English: Harabuchi S, Kosaka A, Yajima Y, Nagata M, Hayashi R, Kumai T, Ohara K, Nagato T, Oikawa K, Ohara M, Harabuchi Y, Ohkuri T, Kobayashi H., Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma. , Biochem Biophys Res Commun , 2020
English: Ohara M, Ohara K, Kumai T, Ohkuri T, Nagato T, Hirata-Nozaki Y, Kosaka A, Nagata M, Hayashi R, Harabuchi S, Yajima Y, Oikawa K, Harabuchi Y, Sumi Y, Furukawa H, Kobayashi H., Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer. , Cancer Immunol Immunother , 2020
English: Yasuaki Harabuchi, Spontaneous Pneumomediastinum: Unusual Cause of Sore Throat. , JJournal of Pediatrics , 2020
English: Ryusuke Hayashi, Toshihiro Nagato, Takumi Kumai, Kenzo Ohara, Mizuho Ohara, Takayuki Ohkuri, Yui Hirata-Nozaki, Shohei Harabuchi, Akemi Kosaka, Marino Nagata, Yuki Yajima, Syunsuke Yasuda, Kensuke Oikawa, Michihisa Kono, Kan Kishibe, Miki Takahara, Akihiro Katada, Tatsuya Hayashi, Esteban Celis, Yasuaki Harabuchi, Hiroya Kobayashi, Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma , Oncoimmunology , 2020
English: Hiroki Komatsuda, Takumi Kumai, Seigo Ueda, Yui Hirata-Nozaki, Tatsuya Hayashi, Yasuaki Harabuchi, Response to PD-1 blockade in a patient with mucosal melanoma of the middle ear: Case report , Clinical case reports. , 2020
English: Michihisa Kono, Risa Wakisaka, Takumi Kumai, Ryusuke Hayashi, Hiroki Komatsuda, Ryosuke Sato, Yasushi Abe, Hidekiyo Yamaki, Miki Takahara, Akihiro Katada, Tatsuya Hayashi, Yasuaki Harabuchi, Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy , Head & neck. , 2020
English: Hiroki Komatsuda, Yoshinori Minami, Yasuaki Harabuchi, Exceptional Response to PD-1 Blockade as First-Line Therapy in Head and Neck Squamous Cell Carcinoma , ORL; journal for oto-rhino-laryngology and its related specialties , 2020
English: Sultan, H.,Kumai, T.,Nagato, T.,Wu, J.,Salazar, AM.,Celis, E., The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mic , Cancer Immunology Immunotherapy , 2019
English: Hirata-Nozaki, Y.,Ohkuri, T.,Ohara, K.,Kumai, T.,Nagata, M.,Harabuchi, S.,Kosaka, A.,Nagato, T.,Ishibashi, K.,Oikawa, K.,Aoki, N.,Ohara, M.,Harabuchi, Y.,Uno, Y.,Takei, H.,Celis, E.,Kobayashi, H., PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma. , Journal of Translational Medicine , 2019
English: Takahara, M.,Nagato, T.,Nozaki, Y.,Kumai, T.,Katada, A.,Hayashi, T.,Harabuchi, Y., A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy , Cellular Immunology , 2019
English: Nagato, T.,Ueda, S.,Takahara, M.,Kishibe, K.,Komabayashi, Y.,Kumai, T.,Ohara, K.,Hirata-Nozaki, Y.,Harabuchi, S.,Hayashi, R.,Ohkuri, T.,Bernasconi, M.,Nadal, D.,Kobayashi, H.,Harabuchi, Y., Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma , Laboratory Investigation , 2019
English: Harabuchi, Y.,Takahara, M.,Kishibe, K.,Nagato, T.,Kumai, T., Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress. , Frontier in Pediatrics , 2019
English: Ohara, K.//Ohkuri, T.//Kumai, T.(Corresponding)//Nagato, T.Nozaki, Y.//Ishibashi, K.//Kosaka, AOhara K,Ohkuri T,Kumai T(corresponding equally),Nagato T,Nozaki Y,Ishibashi K,Kosaka A,Nagata M,,Harabuchi S,Ohara M,Oikawa K,Aoki N,Harabuchi Y,Celis E,Kobayashi H., Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma , OncoImmunology , 2018
English: Redd PS, Lu C, Klement JD, Ibrahim ML, Zhou G, Kumai T, Celis E, Liu K, H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells , OncoImmunology , 2018
English: Sultan H,Wu J,Kumai T,Salazar AM,Celis E., Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice , Cancer Immnulogy, Immunotherapy , 2018
English: H. Sultan, T. Kumai, V, Fesenkova, A. Fan, J. Wu, H. Cho, H. Kobayashi, Y. Harabuchi, E. Celis, Sustained IL2 signaling enhances the antitumor effect of peptide-based vaccines by enhancing T cell expansion and preventing PD-1 inhibition , Cancer Immunology Research , 2018
English: R. Abu-Eid, S. Ahmad, Y. Lin, M. Webb, Z. Berrong, R. Shrimali, T. Kumai, S. Ananth, P. Rodriguez, E. Celis, J. Janik, M. Mkrtichyan, S. Khleif, Enhanced Therapeutic Efficacy and Memory of Tumor Specific CD8 T-cells by ex-vivo PI3K-δ Inhibition , Cancer Research , 2017
English: Nagato,T.,Ohkuri, T.,Ohara, K.,Hirata, Y.,Kishibe, K.,Komabayashi, Y.,Ueda, S.,Takahara, M.,Kumai, T.,Ishibashi, K.,Kosaka,A.,Aoki,N.,Oikawa,K.,Uno,Y.,Akiyama,N.,Sado,M.,Takei,H.,Celis,E.,Harabuchi,Y.,Kobayashi,H., Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy , Cancer Immunology Immunotherapy , 2017
English: Ohkuri, T.,Kosaka, A.,Ishibashi, K.,Kumai, T.,Hirata, Y.,Ohara, K.,Nagato, T.,Oikawa, K.,Aoki, N.,Harabuchi, Y.,Celis, E.,Kobayashi, H., Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site , Cancer Immunology Immunotherapy , 2017
English: T. Kumai, S. Lee, HI Cho, H. Sultan, H. Kobayashi, Y. Harabuchi, E. Celis, Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses. , Cancer Immunology Research , 2017
English: Kumai, T.,Lee, S.,Cho, HI.,Sultan, H.,Kobayashi, H.,Harabuchi, Y.,Celis, E., Optimization of peptide vaccines to induce robust antitumor CD4 T cell responses , Cancer Immunology Research , 2016
English: Kumai, T.,Celis, E.,Rodriguez, PC., A Matter of Survival: HMGB1 regulates autophagy in tumor MDSC , Journal of leukocyte biology , 2016
English: Raber, PL.,Sierra, RA.,Thevenot,PT.,Shuzhong, Z.,Wyczechowska, Dorota.,Kumai, T.,Celis, E.,Rodriguez, PC., T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy. , Oncotarget , 2016
English: Sultan, H.,Fesenkova, V.,Addis, D.,Fan, A.,Kumai, T.,Wu, J.,Salazar, A.,Celis, E. , Designing therapeutic cancer vaccines by mimicking viral infections , Cancer Immunology Immunotherapy , 2016
English: Ishibashi, K.,Kumai, T.,Ohkuri, T,Kosaka, A.,Nagato, T.,Hirata, Y.,Ohara, K.,Oikawa, K.,Aoki, N.,Akiyama, N.,Sado, M.,Kitada, M.,Harabuchi, Y.,Celis, E.,Kobayashi, H., Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy , Oncoimmunology , 2016
English: Kumai, T.,Ohkuri, T.,Nagato, T.,Matsuda, Y.,Oikawa, K.,Aoki, N.,Kimura, S.,Celis, E.,Harabuchi, Y.,Kobayashi, H., Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma , Scientific Reports , 2015
English: Kumai, T.,Oikawa, K.,Aoki, N.,Kimura, S.,Harabuchi, Y.,Kobayashi, H., Assessment of the change in cetuximab induced ADCC activity of NK cells by steroid , Head & Neck , 2015
English: Kumai, T.,Nagato, T.,Kobayashi, H.,Komabayashi, Y.,Ueda, S.,Kishibe, K.,Ohkuri, T.,Takahara, M.,Celis, E.,Harabuchi, Y., CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma , Cancer Immunology Immunotherapy , 2015
English: Kumai, T.,Matsuda, Y.,Ohkuri, T.,Oikawa, K.,Ishibashi, K.,Aoki, N.,Kimura, S.,Harabuchi, Y.,Celis, E.,Kobayashi, H., c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma , Oncoimmunology , 2015
English: Kumai, T.,Oikawa, K.,Aoki, N.,Kimura, S.,Harabuchi, Y.,Celis, E.,Kobayashi, H., Tumor-derived TGF-à and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor , Journal of Translational Medicine , 2014
English: Takumi Kumai,Kei Ishibashi,Kensuke Oikawa,Yoshinari Matsuda,Naoko Aoki,Shoji Kimura,Satoshi Hayashi,Masahiro Kitada,Yasuaki Harabuchi,Esteban Celis,Hiroya Kobayashi, Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53. , Cancer Immunology Immunotherapy , vol.63 (5) (p.469 - 478) , 2014
English: Takumi Kumai,Yoshinari Matsuda,Kensuke Oikawa, Naoko Aoki,Shoji Kimura,Yasuaki Harabuchi,Esteban Celis,Hiroya Kobayashi, EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy. , British Journal of Cancer , vol.109 (8) (p.2155 - 2166) , 2013
English: Kobayashi H, Takumi Kumai, Hayashi S, Matsuda Y, Aoki N, Sato K, Kimura S, Celis E., A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope , Cancer immunology immunotherapy , vol.61 (12) (p.2215 - 2225) , 2012 , (IF:3.7)
English: Hayashi S, Kumai Takumi, Matsuda Y, Aoki N, Sato K, Kimura S, Kitada M, Tateno M, Celis E, Kobayashi H., Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer. , Journal of translational medicine , vol.9 , 2011 , (IF:3.47)
Japanese: Kumai Takumi, Takahara M, Yosida S, Nagato T, Hayashi T, Harabuchi Y , A Case of Nasal/Paranasal Metastatic Renal cell Carcinoma with VEGF Targeted Therapy , Practica Oto-Rhino-Laryngologica , vol.106 (5) (p.423 - 429) , 2013
Japanese: Kumai Takumi, Kishibe K, Yoshida S, Nagato T, Katayama A, Hayashi T, Hatayama N, Harabuchi Y, Four Cases of Mumps with Laryngeal Edema , Practica Oto-Rhino-Laryngologica , vol.105 (3) (p.277 - 284) , 2012
Page: [<<PREV] [1] [NEXT>>]
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.